Latest Global Distribution News

Page 1 of 8
Codan will acquire US mission-critical recording specialist Eventide Communications for about A$244 million, adding evidence capture and AI analytics to Zetron’s command-and-control software. The deal is expected to be mid-single-digit EPS accretive in its first full year, including synergies, but will also add debt and integration costs.
Sophie Babbage
Sophie Babbage
9 Nov 2026
Marine Biomedical has secured US FDA 510(k) clearance for PearlBone, giving Orthocell a clearer path into bone regeneration through its 12% strategic stake and distribution rights. The commercial opportunity is advancing, but revenue, launch timing and definitive distribution arrangements remain undisclosed.
Ada Torres
Ada Torres
3 Nov 2026
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
Biome Australia has reported record pharmacy sell-through, further market-share gains and positive operating cash flow as it begins manufacturing Activated Probiotics domestically. The quarter also moved its China expansion and BMB18 clinical trial closer to key execution milestones.
Ada Torres
Ada Torres
26 Oct 2026
Atomos Limited (ASX:AMS) returned to profit in FY26 as revenue rose 22.5% and EBITDA swung positive, but the recovery remains financially fragile. The video technology group continues to carry negative net assets, used cash in operations and faces a possible covenant shortfall in the December half.
Victor Sage
Victor Sage
30 Sept 2026
Resonance Health has signed a 24-month alliance with London-based Image Analysis Group, making its quantitative MRI endpoints orderable across IAG’s global clinical-trial network. The opportunity is potentially significant, but remains uncontracted: two pilot studies come first, with no minimum revenue or volume commitments.
Victor Sage
Victor Sage
17 Sept 2026
Corporate Travel Management (ASX:CTD) has posted a $17.7 million net profit for FY26, reversing a prior $348.5 million loss, supported by UK client settlements, new debt facilities, and a governance uplift program.
Victor Sage
Victor Sage
4 Sept 2026
Senetas Corporation reported a 4.7% rise in revenue to $20.2 million for FY2026, achieving a strong $4.4 million operating cash flow turnaround. The company advanced its AI governance platform while maintaining a robust sales pipeline and capital management strategy.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Megaport has posted a 37% jump in FY26 revenue to $312 million, driven by strategic acquisitions and a broadening platform across compute, network, and storage. The company raised over $1 billion to fund AI-focused contracts and infrastructure growth.
Sophie Babbage
Sophie Babbage
20 Aug 2026
ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.
Ada Torres
Ada Torres
19 Aug 2026
The Calmer Co. has locked in an exclusive global distribution agreement for its kava extract ingredients, underpinning a potential A$25 million revenue stream over three years across key markets including the US and ASEAN.
Victor Sage
Victor Sage
17 Aug 2026
L1 Group has partnered with Dr Andrew Lin to launch PXC Advisors, a global long short investment manager boasting a 51% annualised return since 2024. The strategy will open to external investors in September 2026 and take over management of the Platinum International Technology Fund.
Claire Turing
Claire Turing
14 Aug 2026

Browse the archive

Full archive